(Q40119298)

English

Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma (English)

1 reference

Europe PubMed Central

17 September 2017

author name string

Guru Sonpavde

1

1 reference

Europe PubMed Central

17 September 2017

Norihiko Okuno

2

1 reference

Europe PubMed Central

17 September 2017

Heidi Weiss

3

1 reference

Europe PubMed Central

17 September 2017

Jiang Yu

4

1 reference

Europe PubMed Central

17 September 2017

Steven S Shen

5

1 reference

Europe PubMed Central

17 September 2017

Mamoun Younes

6

1 reference

Europe PubMed Central

17 September 2017

Weiguo Jian

7

1 reference

Europe PubMed Central

17 September 2017

Seth P Lerner

8

1 reference

Europe PubMed Central

17 September 2017

Carolyn L Smith

9

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

69

1 reference

Europe PubMed Central

17 September 2017

1221-1226

1 reference

Europe PubMed Central

17 September 2017

6

1 reference

Europe PubMed Central

17 September 2017

Mechanisms of estrogen action

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Immunolocalisation of oestrogen receptor beta in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Erratum to “Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract”

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Distribution of estrogen receptors alpha and beta mRNA in mouse urogenital tissues and their expression after oophorectomy and estrogen replacement

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Sex specific expression of progesterone receptor in mouse lower urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Estrogen receptor beta is expressed in human colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Mechanisms of tamoxifen-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Effect of tamoxifen on stromal protein synthesis in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Use of tamoxifen in the treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Tamoxifen enhances the chemosensitivity of bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.02.041

7 January 2021

Identifiers

10.1016/J.UROLOGY.2007.02.041

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40119298&oldid=1886114520"